Objective: Erdheim-Chester disease (ECD) is a rare, non-Langerhans histiocytosis of unknown origin with characteristic radiologic and histologic features. Methods: This report describes a patient with multiple endocrine manifestations in the context of this uncommon disease. Results: A 78-year-old man presented with polyuria, polydypsia, fever, and a constitutional syndrome. Investigations revealed central diabetes insipidus, hypogonadism with inappropriate gonadotropin levels, and mild hyperprolactinemia. Pituitary magnetic resonance imaging showed stalk thickening and absence of the normal bright signal from the posterior pituitary lobe. Orchiectomy biopsy support the diagnosis of ECD, and therapy with peginterferon alfa-2a was initiated. Conclusion: ECD is a multisystemic and heterogeneous clinicopathologic condition. This disease should be considered in patients with diabetes insipidus, hyperprolactinemia, and hypogonadism in the setting of a multi-organ disease. (AACE Clinical Case Rep. 2017;3:e111-e115) Abbreviations: CT = computed tomography; DI = diabetes insipidus; ECD = Erdheim-Chester disease; IGF-1 = insulin-like growth factor 1; 18 FDG-PET/CT = fluorodeoxyglucose-positron emission tomography/computed tomography e112 Multisystemic Involvement in ECD, AACE Clinical Case Rep. 2017;3(No. 2)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.